Literature DB >> 14612199

Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis.

Jens J Kaden1, Carl-Erik Dempfle, Rainer Grobholz, Hanh-Thai Tran, Refika Kiliç, Aslihan Sarikoç, Martina Brueckmann, Christian Vahl, Siegfried Hagl, Karl K Haase, Martin Borggrefe.   

Abstract

Calcific aortic valve stenosis (AS), the main heart valve disease in the elderly, is characterized by extensive remodeling of the extracellular matrix. Matrix metalloproteinases (MMPs) are upregulated in calcific AS and might modulate matrix remodeling. The regulatory mechanisms are unclear. As recent studies have suggested that calcific AS might result from an inflammatory process involving leukocyte invasion and activation, the present study aimed to elucidate the role of the pro-inflammatory cytokine interleukin (IL)-1 beta on MMP expression and cell proliferation in human aortic valves. Immunohistochemistry for leukocytes, IL-1 beta and MMP-1 was performed on aortic valves with (n=6) and without (n=6) calcification obtained at valve replacement or autopsy. Stenotic valves showed marked leukocyte infiltration and associated expression of IL-1 beta and MMP-1. In control valves only scattered leukocytes, low staining for MMP-1 and no staining for IL-1 beta were present. Double-label immunostaining localized IL-1 beta expression mainly to leukocytes and MMP-1 expression to myofibroblasts. Stimulation of cultured human aortic valve myofibroblasts with IL-1 beta lead to a time-dependently increased expression of MMP-1 and MMP-2 by Western blotting and zymography, whereas MMP-9 remained unchanged. Cell proliferation was increased by IL-1 beta as determined by bromodesoxyuridine incorporation. Thus, IL-1 beta may regulate remodeling of the extracellular matrix in calcific AS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14612199     DOI: 10.1016/s0021-9150(03)00284-3

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  81 in total

1.  Risk factors for progression of calcific aortic stenosis and potential therapeutic targets.

Authors:  Ashvin R Kamath; Ramdas G Pai
Journal:  Int J Angiol       Date:  2008

2.  Tissue resident C reactive protein in degenerative aortic valves: correlation with serum C reactive protein concentrations and modification by statins.

Authors:  D Skowasch; S Schrempf; C J Preusse; J A Likungu; A Welz; B Lüderitz; G Bauriedel
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

Review 3.  Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update.

Authors:  Nalini M Rajamannan; Frank J Evans; Elena Aikawa; K Jane Grande-Allen; Linda L Demer; Donald D Heistad; Craig A Simmons; Kristyn S Masters; Patrick Mathieu; Kevin D O'Brien; Frederick J Schoen; Dwight A Towler; Ajit P Yoganathan; Catherine M Otto
Journal:  Circulation       Date:  2011-10-18       Impact factor: 29.690

4.  Matrix metalloproteinases and their regulators are cardiovascular therapeutic targets.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2004-12       Impact factor: 4.599

Review 5.  The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology.

Authors:  Amber C Liu; Vineet R Joag; Avrum I Gotlieb
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

6.  Molecular and functional characteristics of heart-valve interstitial cells.

Authors:  Adrian H Chester; Patricia M Taylor
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-08-29       Impact factor: 6.237

7.  The stretch responsive microRNA miR-148a-3p is a novel repressor of IKBKB, NF-κB signaling, and inflammatory gene expression in human aortic valve cells.

Authors:  Vishal Patel; Katrina Carrion; Andrew Hollands; Andrew Hinton; Thomas Gallegos; Jeffrey Dyo; Roman Sasik; Emma Leire; Gary Hardiman; Salah A Mohamed; Sanjay Nigam; Charles C King; Victor Nizet; Vishal Nigam
Journal:  FASEB J       Date:  2015-01-28       Impact factor: 5.191

Review 8.  Adaptive immune cells in calcific aortic valve disease.

Authors:  Michael A Raddatz; Meena S Madhur; W David Merryman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-03       Impact factor: 4.733

9.  Secreted Factors From Proinflammatory Macrophages Promote an Osteoblast-Like Phenotype in Valvular Interstitial Cells.

Authors:  Joseph C Grim; Brian A Aguado; Brandon J Vogt; Dilara Batan; Cassidy L Andrichik; Megan E Schroeder; Andrea Gonzalez-Rodriguez; F Max Yavitt; Robert M Weiss; Kristi S Anseth
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-09-17       Impact factor: 8.311

Review 10.  Shear-Sensitive Genes in Aortic Valve Endothelium.

Authors:  Joan Fernández Esmerats; Jack Heath; Hanjoong Jo
Journal:  Antioxid Redox Signal       Date:  2016-01-21       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.